Boston Scientific announces cardiac devices' debut in Europe

02/28/2008 | Boston Globe (tiered subscription model), The

Boston Scientific Corp. announced Thursday that doctors have started to use its implantable Cognis cardiac resynchronization therapy defibrillator and its Teligen implantable cardioverter defibrillator for the treatment of cardiac failure and sudden cardiac arrest in European patients.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC